Danh mục

Randomized phase II study of SOX+B-mab versus SOX+C-mab in patients with previously untreated recurrent advanced colorectal cancer with wild-type KRAS (MCSGO-1107 study)

Số trang: 10      Loại file: pdf      Dung lượng: 1.24 MB      Lượt xem: 5      Lượt tải: 0    
tailieu_vip

Xem trước 2 trang đầu tiên của tài liệu này:

Thông tin tài liệu:

Although chemotherapy for metastatic colorectal cancer (mCRC) has improved, the standard chemotherapy regimens for patients with RAS wild-type mCRC remain debated. This study aimed to compare S-1 and oxaliplatin (SOX) + bevacizumab (B-mab) with SOX + cetuximab (C-mab) in patients with previously untreated recurrent advanced CRC with wild-type KRAS.
Nội dung trích xuất từ tài liệu:
Randomized phase II study of SOX+B-mab versus SOX+C-mab in patients with previously untreated recurrent advanced colorectal cancer with wild-type KRAS (MCSGO-1107 study)

Tài liệu được xem nhiều: